Latest Budesonide Stories
Transaction Adds Phase 3-Ready Rare GI Disease Product to Strong Pipeline LEXINGTON, Massachusetts and SAN DIEGO, February 24, 2015 /PRNewswire/ -- Shire plc (LSE:
Serious adverse reactions, including psychiatric, respiratory, thoracic, mediastinal, skin, and subcutaneous disorders, and death were reported in association with use of asthma medications in
SAN DIEGO, Sept. 25, 2014 /PRNewswire/ -- Meritage Pharma, Inc.
LifeScienceIndustryResearch.com adds “Symbicort (Asthma) - Forecast and Market Analysis to 2023” to its store.
DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/s3kv36/investigation) has announced the addition of the "Investigation
PITTSBURGH, June 23, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of Delaware has found after trial that Mylan subsidiary Mylan Pharmaceuticals Inc. does not infringe the asserted claims of U.S. Patent No.
CHICAGO, May 10, 2011 /PRNewswire/ -- Meritage Pharma, Inc.
- an ornament or knob in the shape of a flower